Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
J Thromb Haemost. 2011 Jul;9(7):1359-67. doi: 10.1111/j.1538-7836.2011.04280.x.
Particulate matter (PM) is a key component of ambient air pollution and has been associated with an increased risk of thrombotic events and mortality. The underlying mechanisms remain unclear.
To study the mechanisms of PM-driven procoagulant activity in human plasma and to investigate mainly, the coagulation driven by ultrafine particles (UFPs; < 0.1 μm) in genetically modified mice.
Thrombin generation in response to PM of different sizes was assessed in normal human platelet-poor plasma, as well as in plasmas deficient in the intrinsic pathway proteases factors XII (FXII) or XI (FXI). In addition, UFPs were intratracheally instilled in wild-type (WT) and FXII-deficient (FXII(-/-) ) mice and plasma thrombin generation was analyzed in plasma from treated mice at 4 and 20 h post-exposure.
In normal human plasma, thrombin generation was enhanced in the presence of PM, whereas PM-driven thrombin formation was completely abolished in FXII- and FXI-deficient plasma. UFPs induced a transient increase in tissue factor (TF)-driven thrombin formation at 4 h post-instillation in WT mice compared with saline instillation. Intratracheal instillation of UFPs resulted in a procoagulant response in WT mice plasma at 20 h, whereas it was entirely suppressed in FXII(-/-) mice.
Overall, the data suggest that PM promotes its early procoagulant actions mostly through the TF-driven extrinsic pathway of coagulation, whereas PM-driven long lasting thrombogenic effects are predominantly mediated via formation of activated FXII. Hence, FXII-driven thrombin formation may be relevant to an enhanced thrombotic susceptibility upon chronic exposure to PM in humans.
颗粒物(PM)是环境空气污染的一个关键组成部分,与血栓形成事件和死亡率增加有关。其潜在机制尚不清楚。
研究人类血浆中 PM 驱动的促凝活性的机制,并主要研究基因修饰小鼠中超细颗粒(UFPs;<0.1 μm)驱动的凝血。
在正常人类血小板缺乏的血浆中以及缺乏内在途径蛋白酶因子 XII(FXII)或 XI(FXI)的血浆中,评估了不同大小的 PM 对凝血酶生成的反应。此外,UFPs 通过气管内滴注到野生型(WT)和 FXII 缺陷(FXII(-/-))小鼠中,并在暴露后 4 和 20 小时分析处理小鼠的血浆中凝血酶生成。
在正常人类血浆中,存在 PM 时凝血酶生成增强,而在 FXII 和 FXI 缺乏的血浆中,PM 驱动的凝血酶形成则完全被抑制。UFPs 在 WT 小鼠中诱导 TF 驱动的凝血酶形成在滴注后 4 小时短暂增加,与生理盐水滴注相比。UFPs 的气管内滴注导致 WT 小鼠血浆在 20 小时产生促凝反应,而在 FXII(-/-)小鼠中则完全被抑制。
总的来说,这些数据表明,PM 主要通过 TF 驱动的凝血外途径促进其早期促凝作用,而 PM 驱动的持久血栓形成作用主要通过激活 FXII 的形成来介导。因此,FXII 驱动的凝血酶形成可能与人类慢性暴露于 PM 时血栓形成易感性增加有关。